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TheeﬀectsofStreptococcusthermophilusST28oncytokineproductionbymurinesplenocytesstimulatedwithtransforminggrowth
factor-β plusinterleukin-(IL-)6wereevaluated.TheadditionofST28signiﬁcantlyrepressedIL-17productioncomparedtoATCC
19258 (type strain). ST28 also decreased the number of Th17 cells in the stimulated splenocytes. The anti-inﬂammatory eﬀects of
ST28 administration were evaluated in mice with colitis induced by dextran sodium sulphate (DSS). Oral treatment of mice with
ST28 ameliorated the intestinal lesions by DSS. Upon DSS treatment, IL-17 production in lamina propria lymphocytes (LPLs)
was induced, but ST28 signiﬁcantly decreased its production. ST28 also decreased the percentage of Th17 cells in LPL from DSS-
induced colitis. The present results imply that ST28 suppresses the Th17 response in inﬂamed intestines and would be useful in
the treatment of Th17-mediated diseases, such as inﬂammatory bowel disease.
1.Introduction
A number of studies have documented the potential beneﬁts
of probiotic bacteria which prevent and ameliorate human
T-helper-2-cell- (Th2-) related diseases, such as atopic der-
matitis and asthma [1]. At the helper T-cell level, a number
of probiotic lactobacilli promote the production of T-helper-
1-cel-l (Th1-) skewing cytokines, such as interleukin (IL-) 12
and interferon (IFN-) γ, and suppress the production of IgE
and Th2 cytokines [2]. Other studies have demonstrated that
biﬁdobacteria suppress Th2 cytokine and IgE production,
without signiﬁcant induction of Th1 cytokines [3]. The
Th2-suppressive eﬀect of probiotic bacteria is mediated by
regulatoryT(Treg)cellslinkedtotheinductionofregulatory
cytokines, including IL-10 and transforming growth factor
(TGF-) β [4, 5]. It has been reported that macrophages
stimulatedwithLactococcuslactisW58[4]pr oduceIL -10and
that TGF-β is induced by Lactobacillus paracasei NCC246 in
mixed lymphocyte reactions [5].
In addition, recent clinical studies have proven the
prevention and curative features of probiotics in some
intestinal disorders, such as inﬂammatory bowel diseases
(IBD) including Crohn’s disease and ulcerative colitis. It was
demonstratedthatadministration ofBiﬁdobacteriumlongum
BB536 was eﬀective in inducing remission of patients with
ulcerative colitis [6]. Multiple mechanisms of action have
been suggested to explain the protective eﬀects of probiotics
in intestinal inﬂammation. These can be broadly classiﬁed
as follows: (1) suppression of growth or epithelial bind-
ing/invasion by pathogenic bacteria, (2) improved epithelial
barrier function, and (3) immunoregulatory activities [7].
As for immunoregulation, several probiotics can induce pro-
tective cytokines, including IL-10 and TGF-β, and suppress
pro-inﬂammatory cytokines, such as TNF-α, in the mucosa
of patients with paucities and Crohn’s disease [8].
Besides Th1,Th2, andTreg, Thelper17cells(Th17) have
received considerable recent attention as they exhibit eﬀector
functions distinct from Th1 and Th2 cells [9, 10]. Dif-
ferentiation factors (TGF-β plus IL-6 or IL-21), growth
and stabilization factor (IL-23), and transcription factors
(signal transducer and activator transcription 3 (STAT3),
retinoic acid receptor-related orphan receptor (ROR-) γta n d2 Journal of Biomedicine and Biotechnology
ROR-α) involved in the development of Th17 cells have been
identiﬁed [10].
Notably, Th17 cells produce the pleiotropic cytokine IL-
17,whichpotentlyinducestissueinﬂammationandisassoci-
ated with the pathogenesis of many human diseases, such as
IBD[11]andrheumatoidarthritis[12].Thus,modulationof
Th17 cells is currently viewed as a potentially positive phar-
macological outcome. Although some studies have revealed
thatlacticacidbacteriaandbiﬁdobacteriamayhavepotential
use as anti-inﬂammatory agents in certain chronic inﬂam-
matory diseases, such as IBD [13], it is unclear whether these
b a c t e r i aa r ea b l et os u p p r e s se x c e s sT h 1 7a c t i v i t y .
We recently reported that Biﬁdobacterium longum infan-
tis JCM 1222 (type strain) suppresses IL-17 production
in murine splenocytes in vitro and in inﬂamed intestinal
cultures ex vivo [14]. To identify other bacterial strains
with potential Th17 modulating activity, we previously
performed an in vitro assay with 200 strains of streptococci
and found that Streptococcus thermophilus ST28 exhibited
potent inhibitory activity towards IL-17 production [15].
The main objective of this study was to evaluate the eﬀects of
oral administration of ST28 on IL-17 production by murine
lamina propria lymphocytes (LPLs) and on the expression
of Th17-related surface markers in inﬂamed intestines. We
ﬁrst evaluated and compared in vitro cytokine production
patterns in Th17-skewed conditions following the exposure
of splenocytes to ST28 and ATCC 19258 (type strain).
The in vivo eﬀects of ST28 were also evaluated using ﬂow
cytometry and real-time PCR in dextran-sodium-sulphate-
(DSS-) induced colitis mice, a human IBD model in which
IL-17 plays a pivotal role in pathogenesis [16].
2.MaterialsandMethods
2.1. Bacterial Strains. Two strains of S. thermophilus,A T C C
19258 (type strain) and ST28, were obtained from the
American Type Culture Collection and Glico Dairy Products
(Tokyo, Japan), respectively. Each strain was cultured in M17
broth (Merck, Whitehouse Station, NJ, USA) at 37◦C for 17–
65hours.Theculturedcellswerewashedwithsteriledistilled
water and incubated at 100◦Cf o r5 0 m i n[ 15]. Following
the incubation, the heat-killed bacteria were lyophilized and
used for subsequent experiments.
2.2. Suppressive Eﬀect of S. thermophilus ST28 and ATCC
19258 on In Vitro IL-17 Production in Murine Splenocytes.
Six-week-oldfemaleBalb/cmicewereobtainedfromCharles
River Japan (Kanagawa, Japan), and all experimental pro-
tocols involving animals were approved by the Animal
Care Committee, Graduate School of Biosphere Science,
Hiroshima University. To harvest splenocytes, mice were
sacriﬁced by cervical dislocation, spleens were removed, and
suspensions of splenocytes (1.2 × 106 cells) were incubated
with 2ng/mL TGF-β (R&D Systems, Minneapolis, Minn,
USA) plus 20ng/mL IL-6 (R&D Systems) at 37◦Cf o r7 2
hours in 120μl RPMI 1640 medium (Life Technologies,
Foster City, California, USA) supplemented with 10% fetal
bovine serum (FBS, ICN Biomedicals, Osaka, Japan), 10μM
2-mercaptoethanol, 10mM HEPES, 5 units/mL penicillin
(Life Technologies), and 5μg/mL streptomycin (Life Tech-
nologies) in a 96-well cell culture plate (Thermo Fisher
Scientiﬁc, Waltham, MA, USA). Heat-killed bacteria (1.2 ×
106 cells) were then added to the cell cultures. A culture to
which no TGF-β plus IL-6 or heat-killed bacterial cells were
added was included as a control. Following the incubation,
the plate was centrifuged. Cells were applied to ﬂow cytom-
etry (Figure 1), and culture supernatants were assayed for
cytokine concentrations (Table 1)a sd e s c r i b e db e l o w .
2.3. Flow Cytometric Analysis of Splenocytes. The splenocytes
(1 × 106 cells/mL) were incubated at 37◦Cf o r4h o u r s
in RPMI 1640 medium containing 0.5μg/mL phorbol-
12-myristate-13-acetate (MP Biomedicals, Aurora, Ohio,
USA), 1μg/mL ionomycin (Wako Pure Chemical Indus-
tries, Osaka, Japan), and 3μg/mL brefeldin-A (Wako Pure
Chemical Industries). Then, anti-mouse CD32/16 antibody
was added and incubated 4◦C for 30min. For analysis
of surface markers, ﬂuorescein isothiocyanate (FITC) anti-
mouse CD11c antibody (BioLegend, San Diego, Calif, USA),
allophycocyanin (APC) anti-mouse CD11b antibody (eBio-
science, San Diego, Calif, USA), or APC anti-mouse CD4
antibody (eBioscience) was added to the cell suspension,
which was then incubated in the dark at 4◦C for 30 min.
For isotype controls, FITC-Armenian hamster IgG, APC
rat IgG2aκ (BioLegend), or APC Rat IgG2bκ (eBioscience)
was used. After the incubation, the cells were permeabilized
by IntraPrep (Beckman Coulter, Marseille codex, France)
for intracellular cytokine staining. Phycoerythrin (PE) anti-
mouse IL-17 antibody (eBioscience) or PE rat IgG2aκ
(eBioscience)wasaddedtothecellsuspensionandincubated
in the dark at 4◦C for 30min. Following the incubation, the
cells were washed twice with 5% FBS-Hanks’ balanced salt
solution (HBSS) and suspended in 300μL of 5% FBS-HBSS.
Fluorescence intensity was measured on a Guava Easycyte
ﬂow cytometry system (Millipore, Billerica, Mass, USA).
2.4. Cytokine Measurements. Cytokine (IFN-γ,I L - 2 ,I L -
4, IL-5, IL-10, IL-12(p70), tumor-necrosis-factor- (TNF-)
α, and granulocyte macrophage colony-stimulating factor
(GM-CSF)) concentrations of the culture supernatants were
determined by the microbead method using the Bio-Plex
Suspension Array System (BioRad Laboratories, Hercules,
Calif, USA), according to the manufacturer’s instructions
[17]. Brieﬂy, culture supernatants were incubated with beads
conjugated with anti-IFN-γ, -IL-2, -IL-4, -IL-5, -IL-10,
-IL-12(p70), -TNF-α, and -GM-CSF antibodies (BioRad
Laboratories) followed by sandwich immunoassay using
biotinylated secondary antibodies. The beads were washed
three times after each incubation, and PE-streptavidin was
used as a reporter. The relative ﬂuorescence units were
determined by counting 100 beads using the Bio-Plex
system. Data were evaluated with the Bio-Plex Manager
Software 6.0 (BioRad Laboratories). Separately, the IL-17
concentration of culture supernatants was measured using a
DuoSet Sandwich ELISA Kit (R&D Systems) following the
manufacturer’s instructions.Journal of Biomedicine and Biotechnology 3
Table 1: Changes in cytokine production patterns by murine splenocytes in Th17-skewed conditions by the addition of S. thermophilus
ST28 or S. thermophilus ATCC 19258.
Cytokine (pg/mL) Control TGF-β +I L - 6( + )
(−) S. thermophilus ST28 S. thermophilus ATCC 19258
IL-17 412 ± 17∗∗ 4,383 ± 192 976 ± 21∗∗## 4,858 ± 116
IFN-γ 616 ± 47∗∗ 4,960 ± 105 2,215 ± 369∗∗## 564 ± 91∗∗
IL-2 909 ± 325∗∗ 102 ± 7 1,311 ± 344∗∗## 9,384 ± 96
IL-4 588 ± 30∗∗ n.d. 135 ± 27∗∗## 297 ± 19∗∗
IL-5 453 ± 112∗ 8 ± 46 1 ± 21 115 ± 9
IL-10 1,348 ± 163∗∗ 27,251 ± 2,594 2,550 ± 253∗∗ 2,773 ± 62∗∗
IL-12(p70) 508 ± 64∗∗ 10,778 ± 1,029 985 ± 100∗∗ 1,073 ± 25∗∗
TNF-α 6,259 ± 505∗∗ 52,511 ± 1,123 23,282 ± 3,927∗∗## 5,696 ± 971∗∗
GM-CSF 125 ± 75∗∗ 12,070 ± 1,196 679 ± 117∗∗ 782 ± 29∗∗
n.d., not detected. ∗∗P<0.01, ∗P<0.05 ((−)v e r s u sC o n t r o l ,S. thermophilus ST28, or S. thermophilus ATCC 19258) ##P<0.01 (S. thermophilus ST28 versus
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Figure 1: The suppressive eﬀect of S. thermophilus ST28 on Th17 cells in murine splenocytes. Splenocytes were stimulated with TGF-β plus
IL-6 in the absence (−) or presence of ST28 and applied to ﬂow cytometry. The number of CD4+, CD11b+, and CD11c+ cells in 5,000 IL-17+
cells is indicated. Splenocytes without the stimulation of TGF-β plus IL-6 were used as controls (Cont). ##P<0.01 (S. thermophilus ST28
versus S. thermophilus ATCC 19258). ∗∗P<0.01 ((−)v e r s u sC o n t ,S. thermophilus ST28, or S. thermophilus ATCC 19258). ND, not detected.
2.5. Administration of S. thermophilus ST28 or ATCC 19258 to
DSS-Induced ColitisMice. Six-week-old femaleBALB/c mice
were housed in an air-conditioned room under a 12 hours
light-dark cycle and were allowed ad libitum access to tap
water and a standard diet (MF; Oriental Yeast, Tokyo, Japan).
Acute colitis was induced in mice by adding 3.5% (w/v) DSS
(molecular weight, 36,000–50,000; MP Biomedicals) to their
drinking water for 5 days [18]. The experimental protocols
(Figure 1(a)) were approved by the Animal Care Committee,
GraduateSchoolofBiosphereScience,HiroshimaUniversity.
Animals were randomly divided into four groups (n =
4 each). Group 1 (control group) mice were treated orally
with phosphate-buﬀered saline (PBS) from days 1 to 3, while
Group 2 (control group) received drinking water containing
3.5% (w/v) DSS and were orally administered PBS. Groups
3 and 4 also received drinking water containing 3.5% (w/v)
DSS, and, 24 hours after the start of DSS administration,
the mice were orally administered 107 cfu/day of heat-killed
ST28 (group 3) or ATCC 19258 (group 4) in PBS for 3
c o n s e c u t i v ed a y s( F i g u r e2(a)). The severity of intestinal
inﬂammation was assessed on day 5 by assigning a score
for each of the 2 stool scores, consistency, and bleeding
(Figure 2(b)). The scale used for consistency was 0 (normal
stool), 1 (loose stool), 2 (diarrheal stool), and 3 (watery
stool), and that used for bleeding was 0 (normally colored
stool), 1 (blood visibly present in the stool), 2 (adherent
of blood on anus), and 3 (gross bleeding on anus). Then,
the total score was expressed as the sum of the scores of
the 2 items (total score, 6). After the experimental period,
the entire colon was removed from mice (Figure 2(c)), and
lamina propria from the excised colons was removed.
2.6. Preparation of Lamina Propria Lymphocytes (LPLs).
Pooled (n = 4) colon tissue was suspended in HBSS contain-
ing 10mM dithiothreitol (Wako Pure Chemical Industries)
and incubated at 20◦C for 10min with shaking. The tissue
was further treated with 2.1mg/mL collagenase D (Wako4 Journal of Biomedicine and Biotechnology
3.5% DSS in water
0123 4 5 (day)
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Figure 2: Eﬀects of S. thermophilus ST28 administration on colons of dextran-sodium-sulphate- (DSS-) induced colitis mice. (a) Overview
of the experimental design. Acute colitis was induced in mice (n = 4 for each group) by exposure to 3.5% DSS for 5 days. On days 1–3,
mice were orally administered ST28 cells or ATCC 19258 (107 cfu/day). (b) Inﬂammation score on Day 5. The severity of inﬂammation was
assessed by assigning a score for consistency and bleeding of stool (full score, 6). (c) Colon length on Day 5. Cont, healthy control mice, (−)
untreated DSS-induced colitis mice.
Pure Chemical Industries) at 37◦C for 20min in a shaking
water bath [19, 20]. Only live cells were collected from
single-cell suspensions from the LPLs by Dead Cell Removal
kit (Miltenyi Biotec, Auburn, Calif, USA), and used for
subsequent experiments.
2.7. Ex Vivo Culture of LPLs and Flow Cytometric Analysis.
Portion of LPLs (1 × 106 cells) were suspended in the
same RPMI 1640 medium as described above and incubated
at 37◦C for 48 hours in the presence of 1μg/mL anti-
CD3 (eBioscience) and 1μg/mL anti-CD28 (eBioscience).
Following the incubation, the plate was centrifuged. Cells
were applied to ﬂow cytometry, and culture supernatants
were assayed for IL-17 and IFN-γ concentrations (Figure 3).
For analysis of intracellular IL-17 (Figure 4(a)), LPLs
(1 × 106 cells/mL) were incubated at 37◦Cf o r4h o u r s
in RPMI 1640 medium containing 0.5μg/mL phorbol-
12-myristate-13-acetate, 1μg/mL ionomycin, and 3μg/mL
brefeldin A. Then, APC anti-mouse CD4 antibody or APC
rat IgG2aκ was added to the cell suspension. After the
incubation, the cells were permeabilized by IntraPrep, and
PEanti-mouseIL-17antibodyorPEratIgG2aκwasaddedto
the cell suspension. Following the incubation, the cells were
applied to ﬂow cytometry.
For analysis of surface markers (Figure 4(b)), freshly
prepared LPLs were incubated with FITC anti-mouse CD11c
antibodyandAPCanti-mouseCD86antibody(eBioscience),
or with FITC Armenian hamster IgG and APC rat IgG2aκ,
were added to the cell suspension and applied to ﬂow
cytometry.
2.8. mRNA Expression Analysis of LPLs. Pooled (n = 4)
colon tissue from other DSS colitis mice was suspended
in HBSS containing 5mM EDTA and incubated at 37◦C
for 20min in a shaking water bath. The tissue was further
treated with 1mg/mL collagenase D (Roche Applied Science,
Nonnenwald, Germany) and 3mg/mL dispase II (Life Tech-
nologies) at 37◦C for 30min in a shaking water bath. After
treatment, LPLs were puriﬁed by Percoll density-gradient
centrifugation.Brieﬂy,tissuewasresuspendedin40%Percoll
(GE Healthcare Biosciences AB, Uppsala, Sweden) and
overlaid on 80% Percoll, after which density gradient was
performed by centrifugation at 1,000g for 20min at 25◦C.
LPLs were subsequently collected from the interface fraction
between the 40% and 80% Percoll’s layers [19, 20].
RNA was extracted from the LPLs using TRIzol (Life
Technologies) following the manufacturer’s instructions.
Reverse transcription reactions were performed with High-
Capacity cDNA Reverse Transcription Kit (Life Technolo-
gies) at 25◦C for 10min and 37◦C for 120min. The reaction
was terminated by heating at 85◦C for 5sec, followed















































Figure 3: Eﬀects of S. thermophilus ST28 administration on cytokine production in the lamina propria lymphocytes (LPLs) from DSS-
induced colitis mice. LPLs from DSS-induced mice orally administered ST28 or ATCC 19258 were incubated with anti-CD3 and anti-CD28.
Culture supernatants were harvested and assayed for concentrations of IL-17 (a) and IFN-γ (b). LPLs from untreated DSS-induced colitis














































Figure 4: Eﬀects of S. thermophilus ST28 on percentages of Th17 (a) and inﬂammatory DC (b) in LPLs from DSS-induced colitis mice. (a)
After the experiments described in Figure 3, LPLs from DSS-induced mice orally administered ST28 or ATCC 19258 were incubated with
phorbol-12-myristate-13-acetate, ionomycin, and brefeldin A and applied to ﬂow cytometry to measure intracellular IL-17. (b) Separately,
ﬂow cytometric analysis of surface marker CD86 was performed using freshly prepared LPLs. LPLs from untreated DSS-induced colitis mice
(−) and healthy control mice (Cont) were also assayed. ND, not detected.
KAPA SYBR Fast ABI Prism qPCR Kit (Kapa Biosystems,
Woburn, Mass, USA) and the primer sequences listed
(/see/ in Supplementary Material available on line at doi:
10.1155/2011/378417). Reactions were performed at 95◦C
for 2min, followed by 40 cycles of 95◦Cf o r5s e ca n d6 0 ◦C
for 30sec. The dissociation stage was analyzed at 95◦Cf o r
15sec, followed by 1 cycle of 60◦C for 15sec and 95◦C
for 15sec. The ﬂuorescence of the SYBR green dye was
determined as a function of the PCR cycle number, giving
the threshold cycle number at which ampliﬁcation reached
a signiﬁcant threshold. Data were analysed by the ΔΔCt
method and presented as fold changes in gene expression
after normalization to the internal control β-actin gene
expression level (Supplementary Figure 1).
2.9. Bone Marrow Dendritic Cells (BMDCs). BMDCs were



































































Figure 5: Eﬀects of S. thermophilus ST28 on the production of IL-6 (a) and IL-10 (b) and the percentage of CD86+ cells (c) in bone marrow
dendritic cells (BMDC). LPS-matured BMDC were incubated in the absence (−) or presence of ST28 or ATCC 19258 and assayed for
concentrations of IL-6 (a) and IL-10 (b). CD86+ cells were analyzed by ﬂow cytometry (c). BMDCs without LPS activation were used as
controls (Cont). ∗∗P<0.01, ∗P<0.05 ((−)v e r s u sC o n t ,S. thermophilus ST28, or S. thermophilus ATCC 19258). ND, not detected.
Brieﬂy, bone marrow cells were collected from femurs of six-
week-old female Balb/c mice. Bone marrow mononuclear
cells (2 × 106 cells/mL) were cultured at 37◦Cf o r7d a y s
in RPMI1640 medium containing mouse 200 units/mL
granulocyte macrophage colony-stimulating factor (Mil-
tenyi Biotec), 10% FBS, 10μM 2-mercaptoethanol, 10mM
HEPES, 5 units/mL penicillin, and 5μg/mL streptomycin in
at i s s u ec u l t u r eﬂ a s k .O nd a y7 ,B M D C( 1× 106 cells/mL)
were seeded in 24-well cell culture plate and matured by
1μg/mL lipopolysaccharide (LPS, Sigma-Aldrich, St. Louis,
Mo, USA) for 24 hours. On day 8, heat-killed bacteria (1
× 107 cells/well) were added to the cell cultures. After 24-
hour incubation, the plate was centrifuged. IL-6 and IL-10
concentrations of culture supernatants were measured using
a DuoSet Sandwich ELISA Kit (R&D Systems) following the
manufacturer’s instructions. CD86+ cells were analyzed by
ﬂow cytometry (Figure 5).
2.10. Data Analyses. Statistical analysis was performed using
one-way ANOVA followed by Tukey’s post hoc test. All data
are expressed as the mean ± standard error (S.E.).
3. Results
3.1. S. thermophilus ST28 Suppressed Th17 in Murine Spleno-
cytes. When live ST28 was added to murine splenocytes and
coincubated at 37◦C for 72 hours, ST28 grew in RPMI 1640
medium, and it became impossible to properly examine the
eﬀect of ST28 on splenocytes. Thus, in subsequent experi-
ments, ST28 and ATCC 19258 were used after heat killing.
Prior to the experiment, we ﬁrst puriﬁed T cells from
splenocytes by magnetic bead-based cell separation (MACS),
and stimulated the MACS-puriﬁed T cells with TGF-β
plus IL-6. However, IL-17 production was not detectable
(data not shown), which suggested that IL-17 productionJournal of Biomedicine and Biotechnology 7
from Th17 cells in splenocytes required the coexistence of
non-T cells. Therefore, we alternatively stimulated whole
splenocytes with TGF-β plus IL-6 for further analyses,
after which the stimulated splenocytes were applied to ﬂow
cytometry in order to analyze CD4+, CD11b+, and CD11c+
cells separately. As a result, most of the IL-17+ cells were
CD4+ T cells, which indicated that the major source of IL-17
wasTh17cells.Moreimportantly,itwasconﬁrmedthatST28
decreased the percentage of CD4+ IL-17+ cells (Figure 1).
3.2. S. thermophilus ST28 Modulated In Vitro Cytokine Pro-
duction in Th17-Skewed Conditions. Cytokine production
patterns by murine splenocytes stimulated with TGF-β plus
IL-6 were examined. As shown in Table 1, ST28 signiﬁcantly
(P<0.01, (−) versus ST28) repressed IL-17 production
(78% reduction). On the other hand, ATCC 19258 failed
to repress its production. Based on these results, ST28 was
judged to be a suitable candidate strain for the treatment
of Th17-mediated diseases, and its suppressive eﬀects were
further examined in vivo using DSS-induced colitis mice.
In regard to other cytokines than IL-17, the productions
of all cytokines tested were changed by the stimulation
with TGF-β plus IL-6. Among them, IFN-γ and TNF-α
productions in the ST28 group were signiﬁcantly higher
than those in the ATCC 19258 group, and IL-2 and
IL-4 productions were signiﬁcantly lower. On the other
hand, there were not signiﬁcantly diﬀerences in IL-10
(anti-inﬂammatory cytokine) and IL-12 (proinﬂammatory
cytokines) productions between the two groups.
3.3. S. thermophilus ST28 Suppressed Ex Vivo IL-17 Pro-
duction. Acute colitis was induced in mice by exposure to
3.5% DSS for 5 days, which resulted in an increase in
colon inﬂammation score compared to the control group
(score, 2.5 ± 1.5 versus 0.5 ± 0.3) (Figure 2). However, oral
treatment with ST28 ameliorated the inﬂammation (score,
1.0 ± 0.4). ATCC 19258 exerted the same ameliorative eﬀect
on the intestinal inﬂammation, but the eﬀect was weaker
(Figures 2(b) and 2(c)).
Next, LPLs from the mice was applied to ex vivo culture
experiment (Figure 3). Although diﬀerences in IFN-γ con-
centrations in LPLs culture were not prominent among four
groups, LPLs from DSS colitis mice produced substantial
level of IL-17. However, ST28 markedly suppressed IL-17
production from LPLs culture (86% suppression), while
ATCC 19258 failed to suppress IL-17 production.
From the analyses of mRNA expression in LPLs, it
was revealed that the expression of both IL-17 and ROR-
γt, the master regulator of Th17, in LPLs from the DSS-
administered group was drastically upregulated, compared
to control mice (Supplementary Figure 1). Notably, ST28
markedly inhibited both expressions, which indicated that
ST28 suppressed the diﬀerentiation of na¨ ıve T cells towards
Th17 in LPLs. CD11c and CD86 were also found to be
downregulated by the oral administration of ST28.
It was also conﬁrmed by ﬂow cytometry that CD4+IL17+
cells (Th17 cells) disappeared in LPLs by the oral
administration of both ST28 and ATCC 19258 (Figure 4(a)).
On the other hand, the eﬀects of DSS and those of the
administration of ST28 and ATCC 19258 on CD11c+ CD86+
cells, inﬂammatory dendritic cells (DC), were unclear,
although ATCC 19258 seemed to decrease the percentage of
CD11c+ CD86+ cells. To clarify this point, we next evaluated
the eﬀect of ST28 on DC.
3.4. S. thermophilus ST28 Suppressed Inﬂammatory Responses
in BMDC. The eﬀect of ST28 on LPS-matured BMDC was
evaluated (Figure 5). LPS signiﬁcantly induced IL-6 and
IL-10 productions from BMDC. IL-10 production was not
signiﬁcantly decreased by the addition of ST28 and ATCC
19258. However, both ST28 and ATCC 19258 signiﬁcantly
suppressed IL-6 production. Accordingly, the percentage of
CD86+cells, which is a hallmark of maturation [22], was
also decreased by ST28 and ATCC 19258. Therefore, it is
highly probable that ST28 suppressed Th17 cells via a DC-
dependent mechanism.
4. Discussion
In medical therapy for IBD, the modulation of immune
responses and the regulation of intestinal inﬂammation is
essential. Although the pathogenesis of IBD is complex,
involving environmental, microbial, genetic, and immuno-
logical factors, several recent studies have shown that Th17
cells play a signiﬁcant role in IBD pathology [23, 24]. Here,
we demonstrated that S. thermophilus ST28 repressed IL-
17 production in mouse splenocytes under Th17-skewed
conditions in vitro (Table 1). Moreover, oral treatment of
DSS-induced colitis mice with ST28 suppressed inﬂamma-
tory Th17 cells in LPLs. Although S. thermophilus is not
commonly considered a probiotic bacterium, the ﬁndings
of the present study imply that this species would be useful
in the treatment of IBD by suppressing exaggerated Th17
activity in inﬂamed intestines.
Th1/Th2 balance can inﬂuence the direction and out-
comes of immune responses, due to the mutually antago-
nistic nature of Th1 and Th2 responses. In this regard, the
modulating activity of probiotic and commensal bacteria on
Th1/Th2 balance is commonly evaluated [3, 4]. Here, as
IFN-γ/IL-4 production ratio in ST28 group was high even
in Th17-skewed conditions (Table 1), it is expected that
ST28 would suppress not only Th17, but also Th2 cells.
This response would also aﬀect IgE production in allergic
conditions, because Th2 cells drive IgE class switching by
allergen-stimulated B cells. Suppressing both Th2 and Th17
cells is desirable for the repression of IgE-mediated reaction,
because these cell types are closely related with each other in
allergic patients [25].
To conﬁrm that ST28 also suppressed Th17 cells in vivo,
acute colitis was induced by DSS treatment of mice. DSS
induces acute inﬂammation and recruitment of immune
cells, whose subsequent activation directly causes epithelial
cell [19]. In DSS-induced colitis mice, which serve as a
useful model of human IBD, ST28 administration improved
inﬂammation score (Figure 1), repressed IL-17 production8 Journal of Biomedicine and Biotechnology
(Figure 3), and decreased Th17 cells (Figure 4)i nL P L s
isolated from inﬂamed intestines. Moreover, ST28 decreased
the mRNA expressions of both RORγt and IL-17 in LPLs
(Supplementary Figure 1). Considering all of the data,
we conclude that ST28 suppresses Th17 diﬀerentiation in
the DSS-induced colitis model. Although several lines of
evidence indicate probiotic bacteria have beneﬁcial eﬀectson
DSS colitis [7, 14, 26], the mechanisms by which bacteria
mitigateintestinalinﬂammationhavenotbeenfullyclariﬁed.
We propose that ST28 ameliorates DSS-induced colitis in
mice by suppression of inﬂammatory Th17 cells. It should
be noted that even “heat-killed” bacteria could suppress IL-
17 production in this study. Therefore, some heat-resistant
components of ST28 might exert Th17 supprressive activity.
Theinﬂuenceofheatingconditiononthisactivityisalsonow
evaluated.
The next question is that how ST28 and its responsible
components suppress Th17 cells. It is generally accepted
that bacterial components are recognized by members of
the pattern recognition receptor family, such as Toll-like
receptors (TLRs) [27]. In regard to the epithelial barrier,
some studies have shown that the TLR2 ligand PCSK
amelioratedTNF-α-inducedintestinalbarrierimpairmentin
the human epithelial Caco-2 cells [28, 29] and DSS colitis
mice [29]. It is likely that the recognition of heat-resistant
bacterial components by these kinds of receptors is also
involved in the suppression of Th17 cells.
It has been recently suggested that CD86 plays a critical
role in the initiation of T-cell responses including Th17
cells. For example, gene silencing of CD40, CD80, and
CD86 protected collagen-induced arthritis, one of the Th17-
related inﬂammation [30]. In the eﬀector CD4+ T-cell
responses inducing antigen-induced arthritis, blockade of
CD86 signiﬁcantly suppressed IL-17 production in spleno-
cytes, and CD86 enhanced disease severity by upregulating
IL-17 production [31]. Also, high cell surface expression
of CD86 was observed in patients with IBD [32] and in
mice with CD4+ T-cell-induced colitis [33]. These ﬁndings
lead us to examine the eﬀect of ST28 on the expression of
CD86. The mRNA expressions of CD86 and CD11c were
drastically upregulated in LPLs from DSS colitis mice, but
they were downregulated by the oral administration of ST28
(Supplementary Figure 1). ST28 also signiﬁcantly decreased
the percentage of CD86+cells in matured BMDC (Figure 5).
Collectively, it is highly probable that ST28 ameliorated DSS
induced colitis by suppressing CD86+ DC, which needs to be
clariﬁed in detail.
The function of IL-17 in intestinal inﬂammation has
remained controversial [34]. It has been described that IL-
17 is involved in the pathogenesis of DSS-induced colitis in
mice [16], and IL-17 receptor signaling plays a critical role
in the development of trinitrobenzenesulfonic acid-induced
acute colitis in mice [35], yet another report has suggested
that IL-17 might oﬀer an inhibitory role in the development
of DSS-induced colitis [36]. O’Connor Jr. et al. [37] also
demonstrated the data on a protective function for IL-
17 in T-cell-mediated intestinal inﬂammation. In addition,
several recent studies suggest that Th1 and Th17 both govern
inﬂammation [38]. For example, Buonocore et al. [39]
have recently suggested that a novel innate lymphoid cell
population accumulates in the inﬂamed colon and induces
IL-17 and IFN-γ. Further investigations on Th17/Th1 in the
intestinal inﬂammation are required to clarify the beneﬁcial
functions of ST28 on Th17-mediated diseases.
In conclusion, we have demonstrated that ST28 amelio-
rates intestinal inﬂammation in DSS-induced colitis mice at
least partially through suppression of inﬂammatory Th17
cells. The use of probiotic bacteria in IBD therapy has been
investigated in a number of clinical studies [40]. Although
the eﬃcacy of this treatment approach was demonstrated for
ulcerativecolitis[6],theresultsforCrohn’sdiseasearenotyet
clear owing to conﬂicting results and a paucity of trials [40].
In any case, the majority of the demonstrated curative and
palliative eﬀects of probiotic bacteria appear to be mediated
by modulation of the intestinal immune system. Clinical
approaches using probiotics are appealing due to a lack of
toxicity andpatient desire fortheuseofnaturalphysiological
approaches to treating disease [40]. Since S. thermophilus has
a long history of being safely consumed in yogurt, its further
application to the treatment and/or prevention of Th17-
mediated diseases such as IBD is expected to be beneﬁcial.
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